CIN Clinical Trial
Official title:
Visipaque and Isovue in Cardiac Angiography in Renally Impaired Patients
The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue or Visipaque in patients with moderate to severe renal insufficiency undergoing cardiac angiography. Serum creatinine will be measured before and up to 48-72 hours after the administration of the contrast agent to evaluate renal function.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00339989 -
Cervical Cancer Early Endpoints and Determinants
|
||
Active, not recruiting |
NCT05580341 -
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
|
Phase 3 | |
Recruiting |
NCT03872739 -
To Compare Intravenous and Oral Hydration of the Prevention for CIN in Elderly Patients Undergoing Intravenous CECT
|
N/A | |
Completed |
NCT01766284 -
Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix
|
N/A | |
Completed |
NCT02363244 -
Pap and HPVDNA Before and After Acetic Acid
|
||
Recruiting |
NCT02116920 -
HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening
|
N/A | |
Enrolling by invitation |
NCT01836588 -
New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR
|
N/A | |
Recruiting |
NCT06261879 -
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood
|
N/A | |
Completed |
NCT03239223 -
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
|
Phase 1 | |
Completed |
NCT03791606 -
Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)
|
||
Completed |
NCT04809727 -
Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy
|
N/A |